- Investing Ideas
- Australian Pharmaceuticals & Biotech Nano Cap Stocks
Australian Pharmaceuticals & Biotech Nano Cap Stocks
Results
5
Stocks with a market cap under US$50M.
5 companies
Botanix Pharmaceuticals
Market Cap: AU$60.2m
Operates as a commercial dermatology company in Australia and the United States.
BOT
AU$0.022
7D
-4.3%
1Y
-84.8%
Radiopharm Theranostics
Market Cap: AU$52.1m
A clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs.
RAD
AU$0.012
7D
-7.7%
1Y
-51.0%
Medical Developments International
Market Cap: AU$51.8m
Manufactures and distributes emergency medical solutions in Australia, Asia, Europe, the United States, and internationally.
MVP
AU$0.46
7D
-8.0%
1Y
-35.2%
Trajan Group Holdings
Market Cap: AU$29.0m
Develops, manufactures, and sells analytical and life science products and devices in Malaysia, Japan, Australia, New Zealand, the United States, Europe, the Middle East, Africa, and India.
TRJ
AU$0.19
7D
-5.0%
1Y
-79.5%
Vitura Health
Market Cap: AU$15.9m
Engages in the sale and distribution of medicinal cannabis products in Australia.
VIT
AU$0.024
7D
0%
1Y
-65.7%